Long-term effects on sexual function and fertility after treatment of testicular cancer

British Journal of Cancer

Volumn 80, Issue 5-6, 1999, Pages 801-807

  Hartmann, J T ^a   Albrecht, C ^a   Schmoll, H J ^b   Kuczyk, M A ^c   Kollmannsberger, C ^a   Bokemeyer, C ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Chemotherapy; Fertility aspects; Irradiation; RPLND; Sexual functioning; Testicular cancer

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE; VINBLASTINE; VINCRISTINE;

ADULT; ARTICLE; FOLLOW UP; GERMANY; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MALE FERTILITY; MALE SEXUAL DYSFUNCTION; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; QUESTIONNAIRE; REMISSION; RETROSPECTIVE STUDY; SELF REPORT; SEXUAL FUNCTION; TESTIS CANCER;

ADOLESCENT; ADULT; COMBINED MODALITY THERAPY; FATHERS; FEMALE; FERTILITY; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; SEXUAL DYSFUNCTION, PHYSIOLOGICAL; TESTICULAR NEOPLASMS; TIME FACTORS;

EID: 0032895328     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690424     Document Type: Article

References (54)

1. Aass N, Fossa SD, Theodorson L and Norman N (1991) Prediction of long-term gonadal toxicity after standard treatment for testicular cancer. Eur J Cancer 27: 1087-1091
2. Aass N, Grunfeld B, Kaalhus O and Fossa SD (1993) Pre- and posttreatment sexual life in testicular cancer patients; a descriptive investigation. Br J Cancer 67: 1560-1567
3. Arai Y, Kawakita M, Okada Y and Yoshida O (1997) Sexuality and fertility in long-term survivors of testicular cancer. J Clin Oncol 15: 1444-1448
4. Berthelsen JG and Skakkebaek NE (1984) Sperm counts and serum follicle-stimulating hormone levels before and after radiotherapy and chemotherapy in men with testicular germ cell cancer. Fertil Steril 41: 281-286
5. Bloom JR, Fobair P, Gritz E, Wellisch D, Spiegel D, Varghese A and Hoppe R (1993) Psychosocial outcomes of cancer: a comparative analysis of Hodgkin's disease and testicular cancer. J Clin Oncol 11: 979-988
6. Bokemeyer C (1998) Current trends in chemotherapy for metastatic nonseminomatous testicular germ cell tumors. Oncology 55: 177-188
7. Bokemeyer C, Kohrmann O, Tischler J, Weissbach L, Rath U, Haupt A, Schöffski P, Harstrick A and Schmoll HJ (1996) A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors. Ann Oncol 7: 1015-1021
8. Brenner J, Vugrin D and Whitmore W (1985) Effect of treatment on fertility and sexual function in males with metastatic nonseminomatous germ cell tumours of tests. Am J Clin Oncol 8: 178-182
9. Bruckert E (1991) How frequent in unintentional childlessness in Germany? Andrologica 23: 245-250
10. Buena F, Swerdloff RS, Steiner BS, Lutchmansingh P, Peterson MA, Randian MR, Galmarini M and Bhasin S (1993) Sexual function does not change when serum testosterone levels are pharmacologically varied within the normal male range. Fertil Steril 59: 1118-1123
11. Burns LH (1987) Infertility as boundary ambiguity: one theoretical perspective. Fam Process 26: 359-372
12. Byrne J and Mulvihill JJ (1991) Long-term survivors of childhood and adolescent cancer: their fertility and the health of their offsprings. In Complications of Cancer Management, Plowman PN, McElwain TJ, Meadows AT (eds), pp. 114-127. Butterworth Scientific: Guildford
13. Cassileth BR and Steinfeld AD (1987) Psychological preparation of the patient and family. Cancer 60: 547-552
14. Cavalli F, Monfadini S and Pizzocaro G (1980) Report on the international workshop on staging and treatment of testicular cancer. Eur J Cancer 16: 1367-1372
15. Dodds L, Marrett LD, Tomkins DJ, Green B and Sherman G (1993) Case-control study of congenital anomalies in children of cancer patients. Br Med J 307: 164-168
16. Drasga RE, Einhorn LH, Williams SD, Patel DN and Stevens EE (1983) Fertility after chemotherapy for testicular cancer. J Clin Oncol 3: 179-183
17. Einhorn LH (1990) Treatment of testicular cancer: a new and improved model. J Clin Oncol 8: 1777-1781
18. El-Beheiry A, Souka A, El-Kamshoushi A, Hussein S and El-Sabah K (1988) Hyperprolacteinia and impotence. Arch Androl 21: 211-214
19. Fossa SD, Klepp O and Aakvaag A (1980) Serum hormone levels in patients with malignant testicular germ cell tumours without clinical and/or radiological signs of tumour. Br J Urol 52: 151-157
20. Fossa SD, Ous S, Abyholm T, Norman N and Loeb M (1985) Post-treatment fertility in patients with testicular cancer. II. Influence of cis-platin-based combination chemotherapy and of retroperitoneal surgery on hormone and sperm cell production. Br J Urol 57: 210-214
21. Fossa SD, Abyholm T, Norman N and Jetne V (1986) Post-treatment fertility in patients with testicular cancer. Br J Urol 58: 315-319
22. Fossa SD, Aass N and Kaalhus O (1988) Testicular cancer in young Norwegians. J Surg Oncol 39: 43-63
23. Goldstein I, Feldman MI, Deckers PJ, Babaian RK and Krane RJ (1984) Radiation-associated impotence. A clinical study of its mechanism. JAMA 251: 903-910
24. Gritz ER, Wellisch DK, Wang HJ, Siau J, Landsverk JA and Cosgrove MD (1989) Long-term effects of testicular cancer on sexual functioning in married couples. Cancer 64: 1560-1567
25. Guazzerri S, Lembo A, Ferro G, Artibani W, Merlo F, Zanchelta R and Pagano F (1985) Sperm antibodies and infertility in patients with testicular cancer. Urology 26: 139-142
26. Harstrick A, Schmoll HJ, Kohne-Wompner CH, Bergmann L, Lammers U, Hohnloser J, Dolken G, Reichhardt P, Siegerl W, Natt F, Rath V, Wilke H and Poliwoda H (1991) Cisplatin, etoposide, ifosfamide, vincristine and bleomycin combination chemotherapy for far advanced testicular carcinoma. Ann Oncol 2: 197-202
27. Hartmann JT, Candelaria M, Kuczyk MA, Schmoll HJ and Bokemeyer C (1997a) Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumours (NSGCT). Eur J Cancer 33: 843-847
28. Hartmann JT, Schmoll HJ, Kuczyk MA, Candelaria M and Bokemeyer C (1997b) Post-chemotherapy resections of residual tumor masses from metastastic non-seminomatous germ cell tumours. Ann Oncol 8: 531-538
29. Hendry WF, Stedronska J, Jones CR, Blackmore CA, Barrett A and Peckham MJ (1983) Semen analysis in testicular cancer and Hodgkin's disease: pre- and post-treatment findings and implications for cryopreservation. Br J Urol 55: 769-773
30. Jones DR, Norman AK, Horwich A and Hendry WF (1993) Ejaculatory dysfunction after retroperitoneal lymphadenectomy. Eur Urol 23: 169-171
31. Jonker-Pool G, van Basten JP, Hoekstra HJ, van Driel MF, Sleijfer DT, Koops HS and van de Wiel HB (1997) Sexual functioning after treatment for testicular cancer: comparison of treatment modalities. Cancer 80: 454-464
32. Lampe H, Horwich A, Norman A, Nicholls J and Dearnaley DP (1997) Fertility after chemotherapy for testicular germ cell cancers. J Clin Oncol 15: 239-245
33. Lochrer PJ Sr, Lauer R, Roth BJ, Williams SD, Kalasinski LA and Einhorn LH (1988) Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109: 540-546
34. Moynihan C (1987) Testicular cancer: the psychosocial problems of patients and their relatives. Cancer Surv 6: 477-510
35. Nijman JM, Schraffordt-Koops HS, Kremer J and Sleijfer DT (1987) Gonadal function after surgery and chemotherapy in men with stage II and III non-seminomatous testicular tumors. J Clin Oncol 5: 651-656
36. Petersen PM, Hansen SW, Giwereman A, Rorth M and Skakkebaek NE (1994) Dose-dependent impairment of testicular function in patients treated with cisplatin-based chemotherapy for germ cell cancer. Ann Oncol 5: 355-358
37. Ricker PP, Edbril SD and Garnick MB (1985) Curative testis cancer therapy: psychosocial sequelae. J Clin Oncol 3: 1117-1126
38. Rieker PP, Fitzgerald EM, Kalish LA, Richie JP, Lederman GS, Edbril SD and Garnick MB (1989) Psychosocial factors, curative therapies, and behavioral outcomes. A comparison of testis cancer survivors and a control group of healthy men. Cancer 64: 2399-2407
39. Rieker PP, Fitzgerald EM and Kalish LA (1990) Adaptive behavioral responses to potential infertility among survivors of testis cancer. J Clin Oncol 8: 347-355
40. Sankila R, Olsen JH, Anderson H, Garwicz S, Glattre E, Hertz H, Langmark F, Lanning M, Moller T and Tulinius H (1998) Risk of cancer among offspring of childhood-cancer survivors. N Engl J Med 338: 1339-1344
41. Schmoll HJ, Harstrick A, Bokemeyer C, Dieckmann KP, Clemm C, Berdel WE, Souchon R, Schöber C, Wilke H and Poliwoda H (1993) Single-agent carboplatinum for advanced seminoma. A phase II study. Cancer 72: 237-243
42. Schover LR (1987) Sexuality and fertility in urologic cancer patients. Cancer 60: 553-558
43. Schover LR and von Eschenbach AC (1985) Sexual and marital relationships after treatment for non-seminomatous testicular cancer. Urology 25: 251-255
44. Schover LR, Gonzales M and von Eschenbach AC (1986) Sexual and marital relationships after radiotherapy for seminoma. Urology 27: 117-123
45. Senturia YD and Peckham CS (1990) Children fathered by men treated with chemotherapy for testicular cancer. Eur J Cancer 4: 429-432
46. Sleijfer S, van der Mark TW, Schraffordt-Koops H and Mulder NH (1995) Decrease in pulmonary function during bleomycin-containing combination chemotherapy for testicular canter: not only a bleomycin effect. Br J Cancer 71: 120-123
47. Stoter G, Koopman A, Vendrik CP, Struyvenberg A, Sleyfer DT, Willemse PH, Schraffordt Koops H, van Oosterom AT, ten Bokkel Huinink WW and Pinedo HM (1989) Ten-year survival and late sequelae in testicular cancer patients treated with cisplatin, vinblastine, and bleomycin. J Clin Oncol 7: 1099-1104
48. Tinkler SD, Howard GC and Kerr GR (1992) Sexual morbidity following radiotherapy for germ cell tumours of the testis. Radiother Oncol 25: 207-212
49. Tomic R, Bergman B, Damber JE, Littbrand B and Löfroth PO (1983) Effects of external radiation therapy for cancer of the prostate on the serum concentrations of testosterone, luteinizing hormone and prolactine. J Urol 130: 287-290
50. van Basten JP, Jonker Pool G, van Driel MF, Sleijfer DT, van der Wiel HB and Hockstra HJ (1995) The sexual sequelae of testicular cancer. Cancer Treat Rev 21: 479-495
51. van Basten JP, Hoekstra HJ, van Driel MF, Koops HS, Droste JH, Jonker Pool G, van de Wiel HB and Sleijfer DT (1997a) Sexual dysfunction in nonseminoma testicular cancer patients is related to chemotherapy-induced angiopathy. J Clin Oncol 15: 2442-2448
52. van Basten JP, Jonker-Pool G, van Driel MF, Sleijfer DT, Droste JHJ, van de Wiel HBM, Koops HS, Molenaar WM and Hoekstra HJ (1997b) Sexual functioning after multimodality treatment for disseminated nonseminomalous testicular germ cell tumor. J Urol 158: 1411-1416
53. von Eschenbach AC (1980) Sexual dysfunction following therapy for cancer of the prostate, testis and penis. Front Radiat Ther Oncol 101: 109-116
54. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA and Lochrer PJ (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316: 1435-1440